aHypertension and Lipid Clinic at the State University of Rio de Janeiro
bIguaçu University, Brazil
cHospital Garcia de Orta, Almada, Portugal
dClinic of Cardiovascular Diseases, Institute of Clinical Medicine, Vilnius University Faculty of Medicine, Vilnius, Lithuania
eNational Multi-profile Transport Hospital "Tsar Boris III"- Sofia, Bulgaria
fUniversité de Nantes, CHU Nantes
gCNRS, INSERM, Institut du thorax, F-44000 Nantes, France
hMVZ Verbund Dachau, Akademische Lehrpraxis LMU München, Germany
iDepartment of Clinical and Experimental Medicine, University of Pisa, Italy
jCentre for Cardiovascular Preventions and Outcomes, Institute of Cardiovascular Science, University College London, UK
kFaculty of Médecine and Biomedical Sciences, University of Yaoundé, Cameroon
lDepartment of Essential Hypertension, State Institution “National Scientific Center M.D. Strazhesko Institute of Cardiology” NAMS of Ukraine, Ukraine
mSection of Hypertension, Department of Medicine, St. Luke's Medical Center, Global City, The Philippines
nUniversity of the Philippines
oDept of Medicine, University of Medicine, Yangon, Myanmar
pCarol Davila University of Medicine and Pharmacy
qCardiology Department, Clinical Emergency Hospital Bucharest, Bucharest, Romania
rDepartment of Cardiology, National Cardiovascular Institute
sMedical School, Comenius University, Bratislava, Slovakia
tInternal Medicine and Cardiology Department, Coltea Clinical Hospital, Bucharest, Romania
uDepartment of Hypertension and Diabetology, Translational Medicine Center, Medical University of Gdańsk, Gdańsk, Poland
vAlmazov National Medical Research Centre
wITMO University, Saint-Petersburg, Russia
xDepartment of Pharmacology, Hopital Europeen Georges Pompidou
yParis University, Paris, France
Correspondence to Stephane Laurent, Department of Pharmacology and INSERM U 970, Hôpital Européen Georges Pompidou, Assistance Publique – Hôpitaux de Paris, 56, Rue Leblanc, 75015 Paris, France. Tel: +33 1 56 09 39 91; fax: +33 1 56 09 39 92; e-mail: [email protected]
Abbreviations: ACE, angiotensin-converting enzyme; ARB, AT1 blocker; CCB, calcium channel blockers; CME, continuing medical education; ESH, European Society of Hypertension; MyHEART, My Hypertension Education and Reaching Target; RAAS, renin–angiotensin–aldosterone system; SPC, single-pill combination
Received 3 June, 2020
Revised 26 June, 2020
Accepted 26 June, 2020
